Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

60 Degrees Pharmaceuticals Inc (SXTP)

60 Degrees Pharmaceuticals Inc (SXTP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,336
  • Shares Outstanding, K 4,104
  • Annual Sales, $ 680 K
  • Annual Income, $ -7,950 K
  • EBIT $ -8 M
  • EBITDA $ -4 M
  • 60-Month Beta 2.79
  • Price/Sales 17.97
  • Price/Cash Flow N/A
  • Price/Book N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/25
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -4.65
  • Growth Rate Est. (year over year) +21,583.87%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.1800 +4.24%
on 11/07/25
1.8400 -33.15%
on 10/15/25
-0.2200 (-15.17%)
since 10/07/25
3-Month
1.1800 +4.24%
on 11/07/25
1.8400 -33.15%
on 10/15/25
-0.0900 (-6.82%)
since 08/07/25
52-Week
1.1800 +4.24%
on 11/07/25
12.4500 -90.12%
on 12/11/24
-4.1200 (-77.01%)
since 11/07/24

Most Recent Stories

More News
60 Degrees Pharmaceuticals and NDT Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

ORLANDO, FLORIDA / ACCESS Newswire / October 31, 2025 / RedChip Companies will air interviews with 60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP) and NDT Pharmaceuticals Inc. (OTC:NDTP) on the RedChip...

SXTP : 1.2300 (-5.38%)
NDTP : 1.0300 (+2.23%)
60 Degrees Pharmaceuticals Announces No Detection of Babesia Infection in First Patient Following Treatment with Tafenoquine in Relapsing Babesiosis Study

Breakthrough Therapy Designation request has been submitted to FDA Company to request a Type B meeting with FDA in early 2026 to discuss requirements for a supplementary New Drug Application (sNDA) Results...

SXTP : 1.2300 (-5.38%)
SXTPW : 0.0650 (+35.98%)
60 Degrees Pharmaceuticals Holds Annual Stockholders Meeting

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. 60 Degrees...

SXTP : 1.2300 (-5.38%)
60 Degrees Pharmaceuticals Unveils Name of Chronic Babesiosis Clinical Trial: B-FREE Chronic Babesiosis Study

Company engaged patients diagnosed with chronic babesiosis via social media in a nationwide naming competition A $5K donation from the Company was split between ILADEF and GLA to recognize the winning...

SXTP : 1.2300 (-5.38%)
SXTPW : 0.0650 (+35.98%)
Join 60 Degrees Pharmaceuticals' Exclusive Live Investor Webinar and Q&A Session on October 22

ORLANDO, FLORIDA / ACCESS Newswire / October 2, 2025 / RedChip Companies will host an investor webinar with 60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP)(NASDAQ:SXTPW), a pharmaceutical company focused...

SXTP : 1.2300 (-5.38%)
SXTPW : 0.0650 (+35.98%)
Enlivex Therapeutics and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

ORLANDO, FLORIDA / ACCESS Newswire / September 19, 2025 / RedChip Companies will air interviews with Enlivex Therapeutics Ltd. (Nasdaq:ENLV) and 60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP) on the RedChip...

ENLV : 1.0000 (-0.99%)
SXTP : 1.2300 (-5.38%)
60 Degrees Pharmaceuticals Live Webcast Link and New Date for Presentation at H.C. Wainwright 27th Annual Global Investment Conference

WASHINGTON, Sept. 03, 2025 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (“60 Degrees Pharma” or the “Company”), a pharmaceutical company focused on developing...

SXTP : 1.2300 (-5.38%)
SXTPW : 0.0650 (+35.98%)
60 Degrees Pharmaceuticals to Present at H.C. Wainwright 27th Annual Global Investment Conference

WASHINGTON, Aug. 21, 2025 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (“60 Degrees Pharma” or the “Company”), a pharmaceutical company focused on developing...

SXTP : 1.2300 (-5.38%)
SXTPW : 0.0650 (+35.98%)
60 Degrees Pharmaceuticals Selects Icahn School of Medicine at Mount Sinai as Central Clinical Trial Site for Phase II Study to Evaluate Tafenoquine for Chronic Babesiosis

90-day trial measuring change in general fatigue in chronic babesiosis patients Enrollment expected to commence Q4 2025 and to be completed by Q2 2026 Site has clinical expertise in infectious disease...

SXTP : 1.2300 (-5.38%)
SXTPW : 0.0650 (+35.98%)
60 Degrees Pharmaceuticals Announces Second Quarter 2025 Results

A now resolved supply disruption led to Q2 net product revenue decline but higher profitability due to increased usage of a cash-pay distribution model $1.97 million cash on hand, runway through March...

SXTP : 1.2300 (-5.38%)
SXTPW : 0.0650 (+35.98%)

Business Summary

60 Degrees Pharmaceuticals Inc. specializes in developing and marketing new medicines for the treatment and prevention of infectious diseases. 60 Degrees Pharmaceuticals Inc. is based in WASHINGTON.

See More

Key Turning Points

3rd Resistance Point 1.3615
2nd Resistance Point 1.3152
1st Resistance Point 1.2726
Last Price 1.2300
1st Support Level 1.1837
2nd Support Level 1.1374
3rd Support Level 1.0948

See More

52-Week High 12.4500
Fibonacci 61.8% 8.1449
Fibonacci 50% 6.8150
Fibonacci 38.2% 5.4851
Last Price 1.2300
52-Week Low 1.1800

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar